Pharma Marketing Network

In this 2-minute audio snippet, Silja Chouquet, Owner at whydot GmbH, suggests that pharmaceutical companies should stop trying to market brands via Twitter and focus on using it to support patients.

In this 4.5-minute audio snippet, Pharmaguy discusses how West Virginia and other rural areas are being showered with opioids by drug companies, which could be a major cause in the current flood of drug adverse events.

In this 1-minute audio snippet, Alan Schwarz, National Correspondent at The New York Times and Dr. Aaron Kesselheim, Assistant Professor of Medicine, Brigham and Women's Hospital, discuss the ethics of disease awareness ads -- specifically ADHD awareness ads -- that mention the benefits of a class of drugs without also mentioning the common risks.

In this 1.5-minute audio snippet, Senator Bernie Sanders blasts FDA Commissioner nominee Robert Califf about drug reimportation of FDA-approved Rx Drugs and high drug prices.

In this 2.5-minute audio snippet, Rob Halper, former Director, Corporate Communications and Video Communication, at Johnson & Johnson, talks about the benefits of truly social video. In particular, socially-enabled Youtube videos can be valuable market research tools.

In this 3-minute audio snippet, Rob Halkes, , MHA, Managing Consultant/Owner, Health Business Consult, talks about the structural changes needed to implement a new commercial model for a pharmaceutical marketing approach, which provides added value to medicines, helps physicians provide better care for their patients, and builds a sustainable relationship with customers.

Do you hate your job in pharma? Perhaps, like a friend of mine, your position got eliminated after many years of loyal service. But it may be a blessing in disguise if the behavior of Big Pharma is more and more at odds with your personal values. If so, you have options for cleansing your soul.

In this 4.5-minute audio snippet, R.J., President and CEO of eHealthcare Solutions, talks about programmatic ad buying or the 'Auction-based' model.

In this 3-minute audio snippet, Preeti Pinto, a regulatory consultant and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca, talks about how regulatory-savvy pharma marketers are in a better position to challenge their regulatory colleagues when they say 'No.'

Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.